Skip to content
Menu
Ranked #448

Ascend Vitality

Ascend Vitality is a cash-pay GLP-1 telehealth provider offering compounded semaglutide (starting at $199/mo) and compounded tirzepatide (starting at $299/mo) as both weekly injectables.

Desk Score 53/100 (C) · Verified July 2026

Visit Ascend VitalityAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is Ascend Vitality legit?

Only what Ascend Vitality publishes and what we could check ourselves — nothing inferred. See the methodology.

Certification
Ascend Vitality publishes a LegitScript certification on its own pages.
Where it ships
The site doesn't say which states it serves.
Last checked
July 2026, against Ascend Vitality's own pages.
Published price
Ascend Vitality publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Ascend Vitality cost?" below.
What it sells
Compounded medication only, injectable and oral routes.
Licensing & trust
74/100 on the scored dimension of that name — one of the six in our published methodology.

Checks out on the facts we can verify: a flat month-to-month price and a dated check against the company's own pages, within the states listed above.

What does Ascend Vitality cost?

Each figure exactly as Ascend Vitality publishes it, with the condition attached to it spelled out.

Semaglutide

$199/mo (compounded)

That is a flat month-to-month rate: $199 a month, with no plan term attached to the figure.

Median semaglutide figure across this site: $190 a month, of 164 providers with a published month-to-month price and a check date. Ascend Vitality's $199 a month sits $9 above it.

Tirzepatide

$299/mo (compounded)

That is a flat month-to-month rate: $299 a month, with no plan term attached to the figure.

Median tirzepatide figure across this site: $264 a month, of 163 providers with a published month-to-month price and a check date. Ascend Vitality's $299 a month sits $35 above it.

All figures as published on Ascend Vitality's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
$199/mo
Tirzepatide
$299/mo
Coverage
Not listed on Ascend Vitality's site (checked July 2026)
Brand-name
Compounded only
Verification
Prices as published on Ascend Vitality's site — verified july 2026. Each figure's full condition is in “What does Ascend Vitality cost?” below.

Weigh Ascend Vitality against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: Ascend Vitality vs CoreAge Rx. Because Ascend Vitality dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency28/100
State access24/100
Molecule range83/100
Onboarding speed68/100
Support responsiveness69/100
Licensing & trust74/100

What we like

  • Both injectable and needle-free oral tablet forms of semaglutide and tirzepatide
  • LegitScript certified
  • Transparent cash-pay pricing with cancel-anytime subscription
  • Legal entity and address publicly disclosed (Ascend Vitality LLC, Sheridan, WY)

Where points come off

  • All medications are compounded — FDA does not review compounded drugs for safety/effectiveness
  • No named compounding pharmacy partner disclosed
  • No public state-by-state availability list (homepage cites exclusions: LA, MS, KS, NM, WV)
  • Per-dose/titration pricing not published; only 'starting at' prices shown

The bottom line — C

Best for: Cash-pay compounded semaglutide & tirzepatide, injection or daily tablet.

Ascend Vitality ranks #448 of 542 providers scored — see #1, CoreAge Rx here.

Related reviews

Everyone else here (18)

Pricing and verification reflect Ascend Vitality's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Ascend Vitality's site. Not medical advice; see our disclosure.

← Back to the ranking